We are live on ! Find out more
RJT

Raymond James Trust Portfolio holdings

AUM $4.6B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+13.8%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.1%
AUM
$2.61B
AUM Growth
+$292M
Cap. Flow
+$4.3M
Cap. Flow %
0.16%
Top 10 Hldgs %
19.76%
Holding
1,079
New
101
Increased
398
Reduced
436
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Healthcare 10.65%
3 Financials 10.27%
4 Consumer Staples 8.1%
5 Industrials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VB icon
126
Vanguard Morningstar Small-Cap ETF
VB
$80.7B
$4.1M 0.16%
21,051
+20
+0.1% +$3.53K
PYPL icon
127
PayPal
PYPL
$49.5B
$4.08M 0.16%
17,438
+1,723
+11% +$357K
EG icon
128
Everest Group
EG
$14.4B
$4.08M 0.16%
17,412
+356
+2% +$78.6K
RSP icon
129
Invesco S&P 500 Equal Weight ETF
RSP
$98.1B
$3.8M 0.15%
29,823
+2,736
+10% +$325K
CI icon
130
Cigna
CI
$74.5B
$3.75M 0.14%
18,008
-632
-3% -$124K
MDLZ icon
131
Mondelez International
MDLZ
$78.8B
$3.75M 0.14%
64,072
-8,735
-12% -$499K
HEDJ icon
132
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.86B
$3.72M 0.14%
112,196
BABA icon
133
Alibaba
BABA
$305B
$3.7M 0.14%
15,903
-1,861
-10% -$517K
IVW icon
134
iShares S&P 500 Growth ETF
IVW
$75.5B
$3.69M 0.14%
57,778
+1,526
+3% +$92.5K
GD icon
135
General Dynamics
GD
$103B
$3.64M 0.14%
24,473
-1,204
-5% -$176K
USB icon
136
US Bancorp
USB
$99.6B
$3.63M 0.14%
77,939
+2,858
+4% +$121K
UL icon
137
Unilever
UL
$137B
$3.61M 0.14%
53,188
+14,909
+39% +$1.01M
ECL icon
138
Ecolab
ECL
$78.6B
$3.6M 0.14%
16,638
+803
+5% +$168K
NVS icon
139
Novartis
NVS
$292B
$3.59M 0.14%
37,996
-135
-0.4% -$11.8K
KR icon
140
Kroger
KR
$35.7B
$3.58M 0.14%
112,661
-2,730
-2% -$88.5K
IGIB icon
141
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$3.57M 0.14%
57,824
+4,884
+9% +$299K
DVY icon
142
iShares Select Dividend ETF
DVY
$23.6B
$3.56M 0.14%
37,038
-637
-2% -$57.8K
BDX icon
143
Becton Dickinson
BDX
$46.9B
$3.54M 0.14%
14,485
+535
+4% +$125K
C icon
144
Citigroup
C
$224B
$3.52M 0.13%
57,023
+2,928
+5% +$149K
LOW icon
145
Lowe's Companies
LOW
$119B
$3.49M 0.13%
21,748
-629
-3% -$102K
LQD icon
146
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
$3.45M 0.13%
24,984
+5,424
+28% +$739K
VEU icon
147
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
$3.45M 0.13%
59,072
+13,700
+30% +$747K
CCI icon
148
Crown Castle
CCI
$33.5B
$3.39M 0.13%
21,275
+1,334
+7% +$216K
HYG icon
149
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$3.35M 0.13%
38,381
-922
-2% -$78.9K
JNK icon
150
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.9B
$3.3M 0.13%
30,328
+777
+3% +$82.8K

Similar funds

Raymond James Trust's Q4 2020 Portfolio in Review

As of Q4 2020, Raymond James Trust held 1,079 positions worth $2.61B, up 13% from $2.32B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James Trust's Q4 2020 filing shows 101 new, 398 increased, 436 reduced and 41 closed positions. Its largest new stake was Invesco S&P 500 Pure Value ETF: 22,191 shares worth $1.36M. The largest sale was Fulgent Genetics, an estimated $37.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James Trust's largest Q4 2020 buy was Invesco S&P 500 Pure Value ETF: 22,191 shares worth $1.36M.
  • Raymond James Trust added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $6.25M increase.
  • Raymond James Trust's biggest Q4 2020 reduction was Fulgent Genetics, cutting an estimated $37.7M.
  • Raymond James Trust fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $981K.
  • Raymond James Trust's ten largest holdings make up 20% of its $2.61B portfolio in Q4 2020.
  • Raymond James Trust opened 101 new positions and closed 41 in Q4 2020.
  • Raymond James Trust's portfolio value rose 13% quarter-over-quarter to $2.61B.

Based on Raymond James Trust's 13F filing for Q4 2020, filed 13 Jan 2021.